Global Biological Vaccines Adjuvants Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities, and have been used in human vaccines for more than 90 years.
According to our (Global Info Research) latest study, the global Biological Vaccines Adjuvants market size was valued at USD million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Biological Vaccines Adjuvants market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2022, are provided.
Key Features:
Global Biological Vaccines Adjuvants market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2017-2028
Global Biological Vaccines Adjuvants market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2017-2028
Global Biological Vaccines Adjuvants market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2017-2028
Global Biological Vaccines Adjuvants market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2017-2022
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Biological Vaccines Adjuvants
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Biological Vaccines Adjuvants market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GSK, Dynavax Technologies, Novavax, Agenus and Croda International, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Biological Vaccines Adjuvants market is split by Type and by Application. For the period 2017-2028, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Biological Vaccines Adjuvants product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Biological Vaccines Adjuvants, with price, sales, revenue and global market share of Biological Vaccines Adjuvants from 2017 to 2022.
Chapter 3, the Biological Vaccines Adjuvants competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Biological Vaccines Adjuvants breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Biological Vaccines Adjuvants market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Biological Vaccines Adjuvants.
Chapter 14 and 15, to describe Biological Vaccines Adjuvants sales channel, distributors, customers, research findings and conclusion.
According to our (Global Info Research) latest study, the global Biological Vaccines Adjuvants market size was valued at USD million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Biological Vaccines Adjuvants market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2022, are provided.
Key Features:
Global Biological Vaccines Adjuvants market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2017-2028
Global Biological Vaccines Adjuvants market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2017-2028
Global Biological Vaccines Adjuvants market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2017-2028
Global Biological Vaccines Adjuvants market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2017-2022
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Biological Vaccines Adjuvants
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Biological Vaccines Adjuvants market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GSK, Dynavax Technologies, Novavax, Agenus and Croda International, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Biological Vaccines Adjuvants market is split by Type and by Application. For the period 2017-2028, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Aluminum Adjuvant
- Emulsions Adjuvant
- Others
- Human Vaccine
- Veterinary Vaccine
- GSK
- Dynavax Technologies
- Novavax
- Agenus
- Croda International
- Seppic
- OZ Biosciences
- Phibro Animal Health Corporation
- Associated British Foods
- InvivoGen
- Merck KGaA
- CSL Limited
- Vertellus
- Allergy Therapeutics
- Riboxx GmbH
- CaPtivat? Pharmaceuticals
- EuBiologics
- Pacific GeneTech
- Hawaii Biotech
- Vaxine Pty Ltd.
- Creative Diagnostics
- LiteVax BV
- Mukta Industries
- Oncovir
- TiterMax USA
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Biological Vaccines Adjuvants product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Biological Vaccines Adjuvants, with price, sales, revenue and global market share of Biological Vaccines Adjuvants from 2017 to 2022.
Chapter 3, the Biological Vaccines Adjuvants competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Biological Vaccines Adjuvants breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Biological Vaccines Adjuvants market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Biological Vaccines Adjuvants.
Chapter 14 and 15, to describe Biological Vaccines Adjuvants sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Biological Vaccines Adjuvants Introduction
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Biological Vaccines Adjuvants Consumption Value by Type: 2017 Versus 2021 Versus 2028
1.3.2 Aluminum Adjuvant
1.3.3 Emulsions Adjuvant
1.3.4 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Biological Vaccines Adjuvants Consumption Value by Application: 2017 Versus 2021 Versus 2028
1.4.2 Human Vaccine
1.4.3 Veterinary Vaccine
1.5 Global Biological Vaccines Adjuvants Market Size & Forecast
1.5.1 Global Biological Vaccines Adjuvants Consumption Value (2017 & 2021 & 2028)
1.5.2 Global Biological Vaccines Adjuvants Sales Quantity (2017-2028)
1.5.3 Global Biological Vaccines Adjuvants Average Price (2017-2028)
2 MANUFACTURERS PROFILES
2.1 GSK
2.1.1 GSK Details
2.1.2 GSK Major Business
2.1.3 GSK Biological Vaccines Adjuvants Product and Services
2.1.4 GSK Biological Vaccines Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.1.5 GSK Recent Developments/Updates
2.2 Dynavax Technologies
2.2.1 Dynavax Technologies Details
2.2.2 Dynavax Technologies Major Business
2.2.3 Dynavax Technologies Biological Vaccines Adjuvants Product and Services
2.2.4 Dynavax Technologies Biological Vaccines Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.2.5 Dynavax Technologies Recent Developments/Updates
2.3 Novavax
2.3.1 Novavax Details
2.3.2 Novavax Major Business
2.3.3 Novavax Biological Vaccines Adjuvants Product and Services
2.3.4 Novavax Biological Vaccines Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.3.5 Novavax Recent Developments/Updates
2.4 Agenus
2.4.1 Agenus Details
2.4.2 Agenus Major Business
2.4.3 Agenus Biological Vaccines Adjuvants Product and Services
2.4.4 Agenus Biological Vaccines Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.4.5 Agenus Recent Developments/Updates
2.5 Croda International
2.5.1 Croda International Details
2.5.2 Croda International Major Business
2.5.3 Croda International Biological Vaccines Adjuvants Product and Services
2.5.4 Croda International Biological Vaccines Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.5.5 Croda International Recent Developments/Updates
2.6 Seppic
2.6.1 Seppic Details
2.6.2 Seppic Major Business
2.6.3 Seppic Biological Vaccines Adjuvants Product and Services
2.6.4 Seppic Biological Vaccines Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.6.5 Seppic Recent Developments/Updates
2.7 OZ Biosciences
2.7.1 OZ Biosciences Details
2.7.2 OZ Biosciences Major Business
2.7.3 OZ Biosciences Biological Vaccines Adjuvants Product and Services
2.7.4 OZ Biosciences Biological Vaccines Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.7.5 OZ Biosciences Recent Developments/Updates
2.8 Phibro Animal Health Corporation
2.8.1 Phibro Animal Health Corporation Details
2.8.2 Phibro Animal Health Corporation Major Business
2.8.3 Phibro Animal Health Corporation Biological Vaccines Adjuvants Product and Services
2.8.4 Phibro Animal Health Corporation Biological Vaccines Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.8.5 Phibro Animal Health Corporation Recent Developments/Updates
2.9 Associated British Foods
2.9.1 Associated British Foods Details
2.9.2 Associated British Foods Major Business
2.9.3 Associated British Foods Biological Vaccines Adjuvants Product and Services
2.9.4 Associated British Foods Biological Vaccines Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.9.5 Associated British Foods Recent Developments/Updates
2.10 InvivoGen
2.10.1 InvivoGen Details
2.10.2 InvivoGen Major Business
2.10.3 InvivoGen Biological Vaccines Adjuvants Product and Services
2.10.4 InvivoGen Biological Vaccines Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.10.5 InvivoGen Recent Developments/Updates
2.11 Merck KGaA
2.11.1 Merck KGaA Details
2.11.2 Merck KGaA Major Business
2.11.3 Merck KGaA Biological Vaccines Adjuvants Product and Services
2.11.4 Merck KGaA Biological Vaccines Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.11.5 Merck KGaA Recent Developments/Updates
2.12 CSL Limited
2.12.1 CSL Limited Details
2.12.2 CSL Limited Major Business
2.12.3 CSL Limited Biological Vaccines Adjuvants Product and Services
2.12.4 CSL Limited Biological Vaccines Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.12.5 CSL Limited Recent Developments/Updates
2.13 Vertellus
2.13.1 Vertellus Details
2.13.2 Vertellus Major Business
2.13.3 Vertellus Biological Vaccines Adjuvants Product and Services
2.13.4 Vertellus Biological Vaccines Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.13.5 Vertellus Recent Developments/Updates
2.14 Allergy Therapeutics
2.14.1 Allergy Therapeutics Details
2.14.2 Allergy Therapeutics Major Business
2.14.3 Allergy Therapeutics Biological Vaccines Adjuvants Product and Services
2.14.4 Allergy Therapeutics Biological Vaccines Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.14.5 Allergy Therapeutics Recent Developments/Updates
2.15 Riboxx GmbH
2.15.1 Riboxx GmbH Details
2.15.2 Riboxx GmbH Major Business
2.15.3 Riboxx GmbH Biological Vaccines Adjuvants Product and Services
2.15.4 Riboxx GmbH Biological Vaccines Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.15.5 Riboxx GmbH Recent Developments/Updates
2.16 CaPtivat? Pharmaceuticals
2.16.1 CaPtivat? Pharmaceuticals Details
2.16.2 CaPtivat? Pharmaceuticals Major Business
2.16.3 CaPtivat? Pharmaceuticals Biological Vaccines Adjuvants Product and Services
2.16.4 CaPtivat? Pharmaceuticals Biological Vaccines Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.16.5 CaPtivat? Pharmaceuticals Recent Developments/Updates
2.17 EuBiologics
2.17.1 EuBiologics Details
2.17.2 EuBiologics Major Business
2.17.3 EuBiologics Biological Vaccines Adjuvants Product and Services
2.17.4 EuBiologics Biological Vaccines Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.17.5 EuBiologics Recent Developments/Updates
2.18 Pacific GeneTech
2.18.1 Pacific GeneTech Details
2.18.2 Pacific GeneTech Major Business
2.18.3 Pacific GeneTech Biological Vaccines Adjuvants Product and Services
2.18.4 Pacific GeneTech Biological Vaccines Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.18.5 Pacific GeneTech Recent Developments/Updates
2.19 Hawaii Biotech
2.19.1 Hawaii Biotech Details
2.19.2 Hawaii Biotech Major Business
2.19.3 Hawaii Biotech Biological Vaccines Adjuvants Product and Services
2.19.4 Hawaii Biotech Biological Vaccines Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.19.5 Hawaii Biotech Recent Developments/Updates
2.20 Vaxine Pty Ltd.
2.20.1 Vaxine Pty Ltd. Details
2.20.2 Vaxine Pty Ltd. Major Business
2.20.3 Vaxine Pty Ltd. Biological Vaccines Adjuvants Product and Services
2.20.4 Vaxine Pty Ltd. Biological Vaccines Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.20.5 Vaxine Pty Ltd. Recent Developments/Updates
2.21 Creative Diagnostics
2.21.1 Creative Diagnostics Details
2.21.2 Creative Diagnostics Major Business
2.21.3 Creative Diagnostics Biological Vaccines Adjuvants Product and Services
2.21.4 Creative Diagnostics Biological Vaccines Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.21.5 Creative Diagnostics Recent Developments/Updates
2.22 LiteVax BV
2.22.1 LiteVax BV Details
2.22.2 LiteVax BV Major Business
2.22.3 LiteVax BV Biological Vaccines Adjuvants Product and Services
2.22.4 LiteVax BV Biological Vaccines Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.22.5 LiteVax BV Recent Developments/Updates
2.23 Mukta Industries
2.23.1 Mukta Industries Details
2.23.2 Mukta Industries Major Business
2.23.3 Mukta Industries Biological Vaccines Adjuvants Product and Services
2.23.4 Mukta Industries Biological Vaccines Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.23.5 Mukta Industries Recent Developments/Updates
2.24 Oncovir
2.24.1 Oncovir Details
2.24.2 Oncovir Major Business
2.24.3 Oncovir Biological Vaccines Adjuvants Product and Services
2.24.4 Oncovir Biological Vaccines Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.24.5 Oncovir Recent Developments/Updates
2.25 TiterMax USA
2.25.1 TiterMax USA Details
2.25.2 TiterMax USA Major Business
2.25.3 TiterMax USA Biological Vaccines Adjuvants Product and Services
2.25.4 TiterMax USA Biological Vaccines Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.25.5 TiterMax USA Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: BIOLOGICAL VACCINES ADJUVANTS BY MANUFACTURER
3.1 Global Biological Vaccines Adjuvants Sales Quantity by Manufacturer (2017-2022)
3.2 Global Biological Vaccines Adjuvants Revenue by Manufacturer (2017-2022)
3.3 Global Biological Vaccines Adjuvants Average Price by Manufacturer (2017-2022)
3.4 Market Share Analysis (2021)
3.4.1 Producer Shipments of Biological Vaccines Adjuvants by Manufacturer Revenue ($MM) and Market Share (%): 2021
3.4.2 Top 3 Biological Vaccines Adjuvants Manufacturer Market Share in 2021
3.4.2 Top 6 Biological Vaccines Adjuvants Manufacturer Market Share in 2021
3.5 Biological Vaccines Adjuvants Market: Overall Company Footprint Analysis
3.5.1 Biological Vaccines Adjuvants Market: Region Footprint
3.5.2 Biological Vaccines Adjuvants Market: Company Product Type Footprint
3.5.3 Biological Vaccines Adjuvants Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Biological Vaccines Adjuvants Market Size by Region
4.1.1 Global Biological Vaccines Adjuvants Sales Quantity by Region (2017-2028)
4.1.2 Global Biological Vaccines Adjuvants Consumption Value by Region (2017-2028)
4.1.3 Global Biological Vaccines Adjuvants Average Price by Region (2017-2028)
4.2 North America Biological Vaccines Adjuvants Consumption Value (2017-2028)
4.3 Europe Biological Vaccines Adjuvants Consumption Value (2017-2028)
4.4 Asia-Pacific Biological Vaccines Adjuvants Consumption Value (2017-2028)
4.5 South America Biological Vaccines Adjuvants Consumption Value (2017-2028)
4.6 Middle East and Africa Biological Vaccines Adjuvants Consumption Value (2017-2028)
5 MARKET SEGMENT BY TYPE
5.1 Global Biological Vaccines Adjuvants Sales Quantity by Type (2017-2028)
5.2 Global Biological Vaccines Adjuvants Consumption Value by Type (2017-2028)
5.3 Global Biological Vaccines Adjuvants Average Price by Type (2017-2028)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Biological Vaccines Adjuvants Sales Quantity by Application (2017-2028)
6.2 Global Biological Vaccines Adjuvants Consumption Value by Application (2017-2028)
6.3 Global Biological Vaccines Adjuvants Average Price by Application (2017-2028)
7 NORTH AMERICA
7.1 North America Biological Vaccines Adjuvants Sales Quantity by Type (2017-2028)
7.2 North America Biological Vaccines Adjuvants Sales Quantity by Application (2017-2028)
7.3 North America Biological Vaccines Adjuvants Market Size by Country
7.3.1 North America Biological Vaccines Adjuvants Sales Quantity by Country (2017-2028)
7.3.2 North America Biological Vaccines Adjuvants Consumption Value by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 EUROPE
8.1 Europe Biological Vaccines Adjuvants Sales Quantity by Type (2017-2028)
8.2 Europe Biological Vaccines Adjuvants Sales Quantity by Application (2017-2028)
8.3 Europe Biological Vaccines Adjuvants Market Size by Country
8.3.1 Europe Biological Vaccines Adjuvants Sales Quantity by Country (2017-2028)
8.3.2 Europe Biological Vaccines Adjuvants Consumption Value by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 ASIA-PACIFIC
9.1 Asia-Pacific Biological Vaccines Adjuvants Sales Quantity by Type (2017-2028)
9.2 Asia-Pacific Biological Vaccines Adjuvants Sales Quantity by Application (2017-2028)
9.3 Asia-Pacific Biological Vaccines Adjuvants Market Size by Region
9.3.1 Asia-Pacific Biological Vaccines Adjuvants Sales Quantity by Region (2017-2028)
9.3.2 Asia-Pacific Biological Vaccines Adjuvants Consumption Value by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 SOUTH AMERICA
10.1 South America Biological Vaccines Adjuvants Sales Quantity by Type (2017-2028)
10.2 South America Biological Vaccines Adjuvants Sales Quantity by Application (2017-2028)
10.3 South America Biological Vaccines Adjuvants Market Size by Country
10.3.1 South America Biological Vaccines Adjuvants Sales Quantity by Country (2017-2028)
10.3.2 South America Biological Vaccines Adjuvants Consumption Value by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Biological Vaccines Adjuvants Sales Quantity by Type (2017-2028)
11.2 Middle East & Africa Biological Vaccines Adjuvants Sales Quantity by Application (2017-2028)
11.3 Middle East & Africa Biological Vaccines Adjuvants Market Size by Country
11.3.1 Middle East & Africa Biological Vaccines Adjuvants Sales Quantity by Country (2017-2028)
11.3.2 Middle East & Africa Biological Vaccines Adjuvants Consumption Value by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 MARKET DYNAMICS
12.1 Biological Vaccines Adjuvants Market Drivers
12.2 Biological Vaccines Adjuvants Market Restraints
12.3 Biological Vaccines Adjuvants Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Biological Vaccines Adjuvants and Key Manufacturers
13.2 Manufacturing Costs Percentage of Biological Vaccines Adjuvants
13.3 Biological Vaccines Adjuvants Production Process
13.4 Biological Vaccines Adjuvants Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Biological Vaccines Adjuvants Typical Distributors
14.3 Biological Vaccines Adjuvants Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Biological Vaccines Adjuvants Introduction
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Biological Vaccines Adjuvants Consumption Value by Type: 2017 Versus 2021 Versus 2028
1.3.2 Aluminum Adjuvant
1.3.3 Emulsions Adjuvant
1.3.4 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Biological Vaccines Adjuvants Consumption Value by Application: 2017 Versus 2021 Versus 2028
1.4.2 Human Vaccine
1.4.3 Veterinary Vaccine
1.5 Global Biological Vaccines Adjuvants Market Size & Forecast
1.5.1 Global Biological Vaccines Adjuvants Consumption Value (2017 & 2021 & 2028)
1.5.2 Global Biological Vaccines Adjuvants Sales Quantity (2017-2028)
1.5.3 Global Biological Vaccines Adjuvants Average Price (2017-2028)
2 MANUFACTURERS PROFILES
2.1 GSK
2.1.1 GSK Details
2.1.2 GSK Major Business
2.1.3 GSK Biological Vaccines Adjuvants Product and Services
2.1.4 GSK Biological Vaccines Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.1.5 GSK Recent Developments/Updates
2.2 Dynavax Technologies
2.2.1 Dynavax Technologies Details
2.2.2 Dynavax Technologies Major Business
2.2.3 Dynavax Technologies Biological Vaccines Adjuvants Product and Services
2.2.4 Dynavax Technologies Biological Vaccines Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.2.5 Dynavax Technologies Recent Developments/Updates
2.3 Novavax
2.3.1 Novavax Details
2.3.2 Novavax Major Business
2.3.3 Novavax Biological Vaccines Adjuvants Product and Services
2.3.4 Novavax Biological Vaccines Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.3.5 Novavax Recent Developments/Updates
2.4 Agenus
2.4.1 Agenus Details
2.4.2 Agenus Major Business
2.4.3 Agenus Biological Vaccines Adjuvants Product and Services
2.4.4 Agenus Biological Vaccines Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.4.5 Agenus Recent Developments/Updates
2.5 Croda International
2.5.1 Croda International Details
2.5.2 Croda International Major Business
2.5.3 Croda International Biological Vaccines Adjuvants Product and Services
2.5.4 Croda International Biological Vaccines Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.5.5 Croda International Recent Developments/Updates
2.6 Seppic
2.6.1 Seppic Details
2.6.2 Seppic Major Business
2.6.3 Seppic Biological Vaccines Adjuvants Product and Services
2.6.4 Seppic Biological Vaccines Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.6.5 Seppic Recent Developments/Updates
2.7 OZ Biosciences
2.7.1 OZ Biosciences Details
2.7.2 OZ Biosciences Major Business
2.7.3 OZ Biosciences Biological Vaccines Adjuvants Product and Services
2.7.4 OZ Biosciences Biological Vaccines Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.7.5 OZ Biosciences Recent Developments/Updates
2.8 Phibro Animal Health Corporation
2.8.1 Phibro Animal Health Corporation Details
2.8.2 Phibro Animal Health Corporation Major Business
2.8.3 Phibro Animal Health Corporation Biological Vaccines Adjuvants Product and Services
2.8.4 Phibro Animal Health Corporation Biological Vaccines Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.8.5 Phibro Animal Health Corporation Recent Developments/Updates
2.9 Associated British Foods
2.9.1 Associated British Foods Details
2.9.2 Associated British Foods Major Business
2.9.3 Associated British Foods Biological Vaccines Adjuvants Product and Services
2.9.4 Associated British Foods Biological Vaccines Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.9.5 Associated British Foods Recent Developments/Updates
2.10 InvivoGen
2.10.1 InvivoGen Details
2.10.2 InvivoGen Major Business
2.10.3 InvivoGen Biological Vaccines Adjuvants Product and Services
2.10.4 InvivoGen Biological Vaccines Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.10.5 InvivoGen Recent Developments/Updates
2.11 Merck KGaA
2.11.1 Merck KGaA Details
2.11.2 Merck KGaA Major Business
2.11.3 Merck KGaA Biological Vaccines Adjuvants Product and Services
2.11.4 Merck KGaA Biological Vaccines Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.11.5 Merck KGaA Recent Developments/Updates
2.12 CSL Limited
2.12.1 CSL Limited Details
2.12.2 CSL Limited Major Business
2.12.3 CSL Limited Biological Vaccines Adjuvants Product and Services
2.12.4 CSL Limited Biological Vaccines Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.12.5 CSL Limited Recent Developments/Updates
2.13 Vertellus
2.13.1 Vertellus Details
2.13.2 Vertellus Major Business
2.13.3 Vertellus Biological Vaccines Adjuvants Product and Services
2.13.4 Vertellus Biological Vaccines Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.13.5 Vertellus Recent Developments/Updates
2.14 Allergy Therapeutics
2.14.1 Allergy Therapeutics Details
2.14.2 Allergy Therapeutics Major Business
2.14.3 Allergy Therapeutics Biological Vaccines Adjuvants Product and Services
2.14.4 Allergy Therapeutics Biological Vaccines Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.14.5 Allergy Therapeutics Recent Developments/Updates
2.15 Riboxx GmbH
2.15.1 Riboxx GmbH Details
2.15.2 Riboxx GmbH Major Business
2.15.3 Riboxx GmbH Biological Vaccines Adjuvants Product and Services
2.15.4 Riboxx GmbH Biological Vaccines Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.15.5 Riboxx GmbH Recent Developments/Updates
2.16 CaPtivat? Pharmaceuticals
2.16.1 CaPtivat? Pharmaceuticals Details
2.16.2 CaPtivat? Pharmaceuticals Major Business
2.16.3 CaPtivat? Pharmaceuticals Biological Vaccines Adjuvants Product and Services
2.16.4 CaPtivat? Pharmaceuticals Biological Vaccines Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.16.5 CaPtivat? Pharmaceuticals Recent Developments/Updates
2.17 EuBiologics
2.17.1 EuBiologics Details
2.17.2 EuBiologics Major Business
2.17.3 EuBiologics Biological Vaccines Adjuvants Product and Services
2.17.4 EuBiologics Biological Vaccines Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.17.5 EuBiologics Recent Developments/Updates
2.18 Pacific GeneTech
2.18.1 Pacific GeneTech Details
2.18.2 Pacific GeneTech Major Business
2.18.3 Pacific GeneTech Biological Vaccines Adjuvants Product and Services
2.18.4 Pacific GeneTech Biological Vaccines Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.18.5 Pacific GeneTech Recent Developments/Updates
2.19 Hawaii Biotech
2.19.1 Hawaii Biotech Details
2.19.2 Hawaii Biotech Major Business
2.19.3 Hawaii Biotech Biological Vaccines Adjuvants Product and Services
2.19.4 Hawaii Biotech Biological Vaccines Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.19.5 Hawaii Biotech Recent Developments/Updates
2.20 Vaxine Pty Ltd.
2.20.1 Vaxine Pty Ltd. Details
2.20.2 Vaxine Pty Ltd. Major Business
2.20.3 Vaxine Pty Ltd. Biological Vaccines Adjuvants Product and Services
2.20.4 Vaxine Pty Ltd. Biological Vaccines Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.20.5 Vaxine Pty Ltd. Recent Developments/Updates
2.21 Creative Diagnostics
2.21.1 Creative Diagnostics Details
2.21.2 Creative Diagnostics Major Business
2.21.3 Creative Diagnostics Biological Vaccines Adjuvants Product and Services
2.21.4 Creative Diagnostics Biological Vaccines Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.21.5 Creative Diagnostics Recent Developments/Updates
2.22 LiteVax BV
2.22.1 LiteVax BV Details
2.22.2 LiteVax BV Major Business
2.22.3 LiteVax BV Biological Vaccines Adjuvants Product and Services
2.22.4 LiteVax BV Biological Vaccines Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.22.5 LiteVax BV Recent Developments/Updates
2.23 Mukta Industries
2.23.1 Mukta Industries Details
2.23.2 Mukta Industries Major Business
2.23.3 Mukta Industries Biological Vaccines Adjuvants Product and Services
2.23.4 Mukta Industries Biological Vaccines Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.23.5 Mukta Industries Recent Developments/Updates
2.24 Oncovir
2.24.1 Oncovir Details
2.24.2 Oncovir Major Business
2.24.3 Oncovir Biological Vaccines Adjuvants Product and Services
2.24.4 Oncovir Biological Vaccines Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.24.5 Oncovir Recent Developments/Updates
2.25 TiterMax USA
2.25.1 TiterMax USA Details
2.25.2 TiterMax USA Major Business
2.25.3 TiterMax USA Biological Vaccines Adjuvants Product and Services
2.25.4 TiterMax USA Biological Vaccines Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.25.5 TiterMax USA Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: BIOLOGICAL VACCINES ADJUVANTS BY MANUFACTURER
3.1 Global Biological Vaccines Adjuvants Sales Quantity by Manufacturer (2017-2022)
3.2 Global Biological Vaccines Adjuvants Revenue by Manufacturer (2017-2022)
3.3 Global Biological Vaccines Adjuvants Average Price by Manufacturer (2017-2022)
3.4 Market Share Analysis (2021)
3.4.1 Producer Shipments of Biological Vaccines Adjuvants by Manufacturer Revenue ($MM) and Market Share (%): 2021
3.4.2 Top 3 Biological Vaccines Adjuvants Manufacturer Market Share in 2021
3.4.2 Top 6 Biological Vaccines Adjuvants Manufacturer Market Share in 2021
3.5 Biological Vaccines Adjuvants Market: Overall Company Footprint Analysis
3.5.1 Biological Vaccines Adjuvants Market: Region Footprint
3.5.2 Biological Vaccines Adjuvants Market: Company Product Type Footprint
3.5.3 Biological Vaccines Adjuvants Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Biological Vaccines Adjuvants Market Size by Region
4.1.1 Global Biological Vaccines Adjuvants Sales Quantity by Region (2017-2028)
4.1.2 Global Biological Vaccines Adjuvants Consumption Value by Region (2017-2028)
4.1.3 Global Biological Vaccines Adjuvants Average Price by Region (2017-2028)
4.2 North America Biological Vaccines Adjuvants Consumption Value (2017-2028)
4.3 Europe Biological Vaccines Adjuvants Consumption Value (2017-2028)
4.4 Asia-Pacific Biological Vaccines Adjuvants Consumption Value (2017-2028)
4.5 South America Biological Vaccines Adjuvants Consumption Value (2017-2028)
4.6 Middle East and Africa Biological Vaccines Adjuvants Consumption Value (2017-2028)
5 MARKET SEGMENT BY TYPE
5.1 Global Biological Vaccines Adjuvants Sales Quantity by Type (2017-2028)
5.2 Global Biological Vaccines Adjuvants Consumption Value by Type (2017-2028)
5.3 Global Biological Vaccines Adjuvants Average Price by Type (2017-2028)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Biological Vaccines Adjuvants Sales Quantity by Application (2017-2028)
6.2 Global Biological Vaccines Adjuvants Consumption Value by Application (2017-2028)
6.3 Global Biological Vaccines Adjuvants Average Price by Application (2017-2028)
7 NORTH AMERICA
7.1 North America Biological Vaccines Adjuvants Sales Quantity by Type (2017-2028)
7.2 North America Biological Vaccines Adjuvants Sales Quantity by Application (2017-2028)
7.3 North America Biological Vaccines Adjuvants Market Size by Country
7.3.1 North America Biological Vaccines Adjuvants Sales Quantity by Country (2017-2028)
7.3.2 North America Biological Vaccines Adjuvants Consumption Value by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 EUROPE
8.1 Europe Biological Vaccines Adjuvants Sales Quantity by Type (2017-2028)
8.2 Europe Biological Vaccines Adjuvants Sales Quantity by Application (2017-2028)
8.3 Europe Biological Vaccines Adjuvants Market Size by Country
8.3.1 Europe Biological Vaccines Adjuvants Sales Quantity by Country (2017-2028)
8.3.2 Europe Biological Vaccines Adjuvants Consumption Value by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 ASIA-PACIFIC
9.1 Asia-Pacific Biological Vaccines Adjuvants Sales Quantity by Type (2017-2028)
9.2 Asia-Pacific Biological Vaccines Adjuvants Sales Quantity by Application (2017-2028)
9.3 Asia-Pacific Biological Vaccines Adjuvants Market Size by Region
9.3.1 Asia-Pacific Biological Vaccines Adjuvants Sales Quantity by Region (2017-2028)
9.3.2 Asia-Pacific Biological Vaccines Adjuvants Consumption Value by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 SOUTH AMERICA
10.1 South America Biological Vaccines Adjuvants Sales Quantity by Type (2017-2028)
10.2 South America Biological Vaccines Adjuvants Sales Quantity by Application (2017-2028)
10.3 South America Biological Vaccines Adjuvants Market Size by Country
10.3.1 South America Biological Vaccines Adjuvants Sales Quantity by Country (2017-2028)
10.3.2 South America Biological Vaccines Adjuvants Consumption Value by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Biological Vaccines Adjuvants Sales Quantity by Type (2017-2028)
11.2 Middle East & Africa Biological Vaccines Adjuvants Sales Quantity by Application (2017-2028)
11.3 Middle East & Africa Biological Vaccines Adjuvants Market Size by Country
11.3.1 Middle East & Africa Biological Vaccines Adjuvants Sales Quantity by Country (2017-2028)
11.3.2 Middle East & Africa Biological Vaccines Adjuvants Consumption Value by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 MARKET DYNAMICS
12.1 Biological Vaccines Adjuvants Market Drivers
12.2 Biological Vaccines Adjuvants Market Restraints
12.3 Biological Vaccines Adjuvants Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Biological Vaccines Adjuvants and Key Manufacturers
13.2 Manufacturing Costs Percentage of Biological Vaccines Adjuvants
13.3 Biological Vaccines Adjuvants Production Process
13.4 Biological Vaccines Adjuvants Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Biological Vaccines Adjuvants Typical Distributors
14.3 Biological Vaccines Adjuvants Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Biological Vaccines Adjuvants Consumption Value by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Biological Vaccines Adjuvants Consumption Value by Application, (USD Million), 2017 & 2021 & 2028
Table 3. GSK Basic Information, Manufacturing Base and Competitors
Table 4. GSK Major Business
Table 5. GSK Biological Vaccines Adjuvants Product and Services
Table 6. GSK Biological Vaccines Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 7. GSK Recent Developments/Updates
Table 8. Dynavax Technologies Basic Information, Manufacturing Base and Competitors
Table 9. Dynavax Technologies Major Business
Table 10. Dynavax Technologies Biological Vaccines Adjuvants Product and Services
Table 11. Dynavax Technologies Biological Vaccines Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 12. Dynavax Technologies Recent Developments/Updates
Table 13. Novavax Basic Information, Manufacturing Base and Competitors
Table 14. Novavax Major Business
Table 15. Novavax Biological Vaccines Adjuvants Product and Services
Table 16. Novavax Biological Vaccines Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 17. Novavax Recent Developments/Updates
Table 18. Agenus Basic Information, Manufacturing Base and Competitors
Table 19. Agenus Major Business
Table 20. Agenus Biological Vaccines Adjuvants Product and Services
Table 21. Agenus Biological Vaccines Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 22. Agenus Recent Developments/Updates
Table 23. Croda International Basic Information, Manufacturing Base and Competitors
Table 24. Croda International Major Business
Table 25. Croda International Biological Vaccines Adjuvants Product and Services
Table 26. Croda International Biological Vaccines Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 27. Croda International Recent Developments/Updates
Table 28. Seppic Basic Information, Manufacturing Base and Competitors
Table 29. Seppic Major Business
Table 30. Seppic Biological Vaccines Adjuvants Product and Services
Table 31. Seppic Biological Vaccines Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 32. Seppic Recent Developments/Updates
Table 33. OZ Biosciences Basic Information, Manufacturing Base and Competitors
Table 34. OZ Biosciences Major Business
Table 35. OZ Biosciences Biological Vaccines Adjuvants Product and Services
Table 36. OZ Biosciences Biological Vaccines Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 37. OZ Biosciences Recent Developments/Updates
Table 38. Phibro Animal Health Corporation Basic Information, Manufacturing Base and Competitors
Table 39. Phibro Animal Health Corporation Major Business
Table 40. Phibro Animal Health Corporation Biological Vaccines Adjuvants Product and Services
Table 41. Phibro Animal Health Corporation Biological Vaccines Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 42. Phibro Animal Health Corporation Recent Developments/Updates
Table 43. Associated British Foods Basic Information, Manufacturing Base and Competitors
Table 44. Associated British Foods Major Business
Table 45. Associated British Foods Biological Vaccines Adjuvants Product and Services
Table 46. Associated British Foods Biological Vaccines Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 47. Associated British Foods Recent Developments/Updates
Table 48. InvivoGen Basic Information, Manufacturing Base and Competitors
Table 49. InvivoGen Major Business
Table 50. InvivoGen Biological Vaccines Adjuvants Product and Services
Table 51. InvivoGen Biological Vaccines Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 52. InvivoGen Recent Developments/Updates
Table 53. Merck KGaA Basic Information, Manufacturing Base and Competitors
Table 54. Merck KGaA Major Business
Table 55. Merck KGaA Biological Vaccines Adjuvants Product and Services
Table 56. Merck KGaA Biological Vaccines Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 57. Merck KGaA Recent Developments/Updates
Table 58. CSL Limited Basic Information, Manufacturing Base and Competitors
Table 59. CSL Limited Major Business
Table 60. CSL Limited Biological Vaccines Adjuvants Product and Services
Table 61. CSL Limited Biological Vaccines Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 62. CSL Limited Recent Developments/Updates
Table 63. Vertellus Basic Information, Manufacturing Base and Competitors
Table 64. Vertellus Major Business
Table 65. Vertellus Biological Vaccines Adjuvants Product and Services
Table 66. Vertellus Biological Vaccines Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 67. Vertellus Recent Developments/Updates
Table 68. Allergy Therapeutics Basic Information, Manufacturing Base and Competitors
Table 69. Allergy Therapeutics Major Business
Table 70. Allergy Therapeutics Biological Vaccines Adjuvants Product and Services
Table 71. Allergy Therapeutics Biological Vaccines Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 72. Allergy Therapeutics Recent Developments/Updates
Table 73. Riboxx GmbH Basic Information, Manufacturing Base and Competitors
Table 74. Riboxx GmbH Major Business
Table 75. Riboxx GmbH Biological Vaccines Adjuvants Product and Services
Table 76. Riboxx GmbH Biological Vaccines Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Riboxx GmbH Recent Developments/Updates
Table 78. CaPtivat? Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 79. CaPtivat? Pharmaceuticals Major Business
Table 80. CaPtivat? Pharmaceuticals Biological Vaccines Adjuvants Product and Services
Table 81. CaPtivat? Pharmaceuticals Biological Vaccines Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 82. CaPtivat? Pharmaceuticals Recent Developments/Updates
Table 83. EuBiologics Basic Information, Manufacturing Base and Competitors
Table 84. EuBiologics Major Business
Table 85. EuBiologics Biological Vaccines Adjuvants Product and Services
Table 86. EuBiologics Biological Vaccines Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 87. EuBiologics Recent Developments/Updates
Table 88. Pacific GeneTech Basic Information, Manufacturing Base and Competitors
Table 89. Pacific GeneTech Major Business
Table 90. Pacific GeneTech Biological Vaccines Adjuvants Product and Services
Table 91. Pacific GeneTech Biological Vaccines Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 92. Pacific GeneTech Recent Developments/Updates
Table 93. Hawaii Biotech Basic Information, Manufacturing Base and Competitors
Table 94. Hawaii Biotech Major Business
Table 95. Hawaii Biotech Biological Vaccines Adjuvants Product and Services
Table 96. Hawaii Biotech Biological Vaccines Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 97. Hawaii Biotech Recent Developments/Updates
Table 98. Vaxine Pty Ltd. Basic Information, Manufacturing Base and Competitors
Table 99. Vaxine Pty Ltd. Major Business
Table 100. Vaxine Pty Ltd. Biological Vaccines Adjuvants Product and Services
Table 101. Vaxine Pty Ltd. Biological Vaccines Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 102. Vaxine Pty Ltd. Recent Developments/Updates
Table 103. Creative Diagnostics Basic Information, Manufacturing Base and Competitors
Table 104. Creative Diagnostics Major Business
Table 105. Creative Diagnostics Biological Vaccines Adjuvants Product and Services
Table 106. Creative Diagnostics Biological Vaccines Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. Creative Diagnostics Recent Developments/Updates
Table 108. LiteVax BV Basic Information, Manufacturing Base and Competitors
Table 109. LiteVax BV Major Business
Table 110. LiteVax BV Biological Vaccines Adjuvants Product and Services
Table 111. LiteVax BV Biological Vaccines Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 112. LiteVax BV Recent Developments/Updates
Table 113. Mukta Industries Basic Information, Manufacturing Base and Competitors
Table 114. Mukta Industries Major Business
Table 115. Mukta Industries Biological Vaccines Adjuvants Product and Services
Table 116. Mukta Industries Biological Vaccines Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 117. Mukta Industries Recent Developments/Updates
Table 118. Oncovir Basic Information, Manufacturing Base and Competitors
Table 119. Oncovir Major Business
Table 120. Oncovir Biological Vaccines Adjuvants Product and Services
Table 121. Oncovir Biological Vaccines Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 122. Oncovir Recent Developments/Updates
Table 123. TiterMax USA Basic Information, Manufacturing Base and Competitors
Table 124. TiterMax USA Major Business
Table 125. TiterMax USA Biological Vaccines Adjuvants Product and Services
Table 126. TiterMax USA Biological Vaccines Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 127. TiterMax USA Recent Developments/Updates
Table 128. Global Biological Vaccines Adjuvants Sales Quantity by Manufacturer (2017-2022) & (K Units)
Table 129. Global Biological Vaccines Adjuvants Revenue by Manufacturer (2017-2022) & (USD Million)
Table 130. Global Biological Vaccines Adjuvants Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 131. Market Position of Manufacturers in Biological Vaccines Adjuvants, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2021
Table 132. Head Office and Biological Vaccines Adjuvants Production Site of Key Manufacturer
Table 133. Biological Vaccines Adjuvants Market: Company Product Type Footprint
Table 134. Biological Vaccines Adjuvants Market: Company Product Application Footprint
Table 135. Biological Vaccines Adjuvants New Market Entrants and Barriers to Market Entry
Table 136. Biological Vaccines Adjuvants Mergers, Acquisition, Agreements, and Collaborations
Table 137. Global Biological Vaccines Adjuvants Sales Quantity by Region (2017-2022) & (K Units)
Table 138. Global Biological Vaccines Adjuvants Sales Quantity by Region (2023-2028) & (K Units)
Table 139. Global Biological Vaccines Adjuvants Consumption Value by Region (2017-2022) & (USD Million)
Table 140. Global Biological Vaccines Adjuvants Consumption Value by Region (2023-2028) & (USD Million)
Table 141. Global Biological Vaccines Adjuvants Average Price by Region (2017-2022) & (US$/Unit)
Table 142. Global Biological Vaccines Adjuvants Average Price by Region (2023-2028) & (US$/Unit)
Table 143. Global Biological Vaccines Adjuvants Sales Quantity by Type (2017-2022) & (K Units)
Table 144. Global Biological Vaccines Adjuvants Sales Quantity by Type (2023-2028) & (K Units)
Table 145. Global Biological Vaccines Adjuvants Consumption Value by Type (2017-2022) & (USD Million)
Table 146. Global Biological Vaccines Adjuvants Consumption Value by Type (2023-2028) & (USD Million)
Table 147. Global Biological Vaccines Adjuvants Average Price by Type (2017-2022) & (US$/Unit)
Table 148. Global Biological Vaccines Adjuvants Average Price by Type (2023-2028) & (US$/Unit)
Table 149. Global Biological Vaccines Adjuvants Sales Quantity by Application (2017-2022) & (K Units)
Table 150. Global Biological Vaccines Adjuvants Sales Quantity by Application (2023-2028) & (K Units)
Table 151. Global Biological Vaccines Adjuvants Consumption Value by Application (2017-2022) & (USD Million)
Table 152. Global Biological Vaccines Adjuvants Consumption Value by Application (2023-2028) & (USD Million)
Table 153. Global Biological Vaccines Adjuvants Average Price by Application (2017-2022) & (US$/Unit)
Table 154. Global Biological Vaccines Adjuvants Average Price by Application (2023-2028) & (US$/Unit)
Table 155. North America Biological Vaccines Adjuvants Sales Quantity by Type (2017-2022) & (K Units)
Table 156. North America Biological Vaccines Adjuvants Sales Quantity by Type (2023-2028) & (K Units)
Table 157. North America Biological Vaccines Adjuvants Sales Quantity by Application (2017-2022) & (K Units)
Table 158. North America Biological Vaccines Adjuvants Sales Quantity by Application (2023-2028) & (K Units)
Table 159. North America Biological Vaccines Adjuvants Sales Quantity by Country (2017-2022) & (K Units)
Table 160. North America Biological Vaccines Adjuvants Sales Quantity by Country (2023-2028) & (K Units)
Table 161. North America Biological Vaccines Adjuvants Consumption Value by Country (2017-2022) & (USD Million)
Table 162. North America Biological Vaccines Adjuvants Consumption Value by Country (2023-2028) & (USD Million)
Table 163. Europe Biological Vaccines Adjuvants Sales Quantity by Type (2017-2022) & (K Units)
Table 164. Europe Biological Vaccines Adjuvants Sales Quantity by Type (2023-2028) & (K Units)
Table 165. Europe Biological Vaccines Adjuvants Sales Quantity by Application (2017-2022) & (K Units)
Table 166. Europe Biological Vaccines Adjuvants Sales Quantity by Application (2023-2028) & (K Units)
Table 167. Europe Biological Vaccines Adjuvants Sales Quantity by Country (2017-2022) & (K Units)
Table 168. Europe Biological Vaccines Adjuvants Sales Quantity by Country (2023-2028) & (K Units)
Table 169. Europe Biological Vaccines Adjuvants Consumption Value by Country (2017-2022) & (USD Million)
Table 170. Europe Biological Vaccines Adjuvants Consumption Value by Country (2023-2028) & (USD Million)
Table 171. Asia-Pacific Biological Vaccines Adjuvants Sales Quantity by Type (2017-2022) & (K Units)
Table 172. Asia-Pacific Biological Vaccines Adjuvants Sales Quantity by Type (2023-2028) & (K Units)
Table 173. Asia-Pacific Biological Vaccines Adjuvants Sales Quantity by Application (2017-2022) & (K Units)
Table 174. Asia-Pacific Biological Vaccines Adjuvants Sales Quantity by Application (2023-2028) & (K Units)
Table 175. Asia-Pacific Biological Vaccines Adjuvants Sales Quantity by Region (2017-2022) & (K Units)
Table 176. Asia-Pacific Biological Vaccines Adjuvants Sales Quantity by Region (2023-2028) & (K Units)
Table 177. Asia-Pacific Biological Vaccines Adjuvants Consumption Value by Region (2017-2022) & (USD Million)
Table 178. Asia-Pacific Biological Vaccines Adjuvants Consumption Value by Region (2023-2028) & (USD Million)
Table 179. South America Biological Vaccines Adjuvants Sales Quantity by Type (2017-2022) & (K Units)
Table 180. South America Biological Vaccines Adjuvants Sales Quantity by Type (2023-2028) & (K Units)
Table 181. South America Biological Vaccines Adjuvants Sales Quantity by Application (2017-2022) & (K Units)
Table 182. South America Biological Vaccines Adjuvants Sales Quantity by Application (2023-2028) & (K Units)
Table 183. South America Biological Vaccines Adjuvants Sales Quantity by Country (2017-2022) & (K Units)
Table 184. South America Biological Vaccines Adjuvants Sales Quantity by Country (2023-2028) & (K Units)
Table 185. South America Biological Vaccines Adjuvants Consumption Value by Country (2017-2022) & (USD Million)
Table 186. South America Biological Vaccines Adjuvants Consumption Value by Country (2023-2028) & (USD Million)
Table 187. Middle East & Africa Biological Vaccines Adjuvants Sales Quantity by Type (2017-2022) & (K Units)
Table 188. Middle East & Africa Biological Vaccines Adjuvants Sales Quantity by Type (2023-2028) & (K Units)
Table 189. Middle East & Africa Biological Vaccines Adjuvants Sales Quantity by Application (2017-2022) & (K Units)
Table 190. Middle East & Africa Biological Vaccines Adjuvants Sales Quantity by Application (2023-2028) & (K Units)
Table 191. Middle East & Africa Biological Vaccines Adjuvants Sales Quantity by Region (2017-2022) & (K Units)
Table 192. Middle East & Africa Biological Vaccines Adjuvants Sales Quantity by Region (2023-2028) & (K Units)
Table 193. Middle East & Africa Biological Vaccines Adjuvants Consumption Value by Region (2017-2022) & (USD Million)
Table 194. Middle East & Africa Biological Vaccines Adjuvants Consumption Value by Region (2023-2028) & (USD Million)
Table 195. Biological Vaccines Adjuvants Raw Material
Table 196. Key Manufacturers of Biological Vaccines Adjuvants Raw Materials
Table 197. Biological Vaccines Adjuvants Typical Distributors
Table 198. Biological Vaccines Adjuvants Typical Customers
Table 1. Global Biological Vaccines Adjuvants Consumption Value by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Biological Vaccines Adjuvants Consumption Value by Application, (USD Million), 2017 & 2021 & 2028
Table 3. GSK Basic Information, Manufacturing Base and Competitors
Table 4. GSK Major Business
Table 5. GSK Biological Vaccines Adjuvants Product and Services
Table 6. GSK Biological Vaccines Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 7. GSK Recent Developments/Updates
Table 8. Dynavax Technologies Basic Information, Manufacturing Base and Competitors
Table 9. Dynavax Technologies Major Business
Table 10. Dynavax Technologies Biological Vaccines Adjuvants Product and Services
Table 11. Dynavax Technologies Biological Vaccines Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 12. Dynavax Technologies Recent Developments/Updates
Table 13. Novavax Basic Information, Manufacturing Base and Competitors
Table 14. Novavax Major Business
Table 15. Novavax Biological Vaccines Adjuvants Product and Services
Table 16. Novavax Biological Vaccines Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 17. Novavax Recent Developments/Updates
Table 18. Agenus Basic Information, Manufacturing Base and Competitors
Table 19. Agenus Major Business
Table 20. Agenus Biological Vaccines Adjuvants Product and Services
Table 21. Agenus Biological Vaccines Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 22. Agenus Recent Developments/Updates
Table 23. Croda International Basic Information, Manufacturing Base and Competitors
Table 24. Croda International Major Business
Table 25. Croda International Biological Vaccines Adjuvants Product and Services
Table 26. Croda International Biological Vaccines Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 27. Croda International Recent Developments/Updates
Table 28. Seppic Basic Information, Manufacturing Base and Competitors
Table 29. Seppic Major Business
Table 30. Seppic Biological Vaccines Adjuvants Product and Services
Table 31. Seppic Biological Vaccines Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 32. Seppic Recent Developments/Updates
Table 33. OZ Biosciences Basic Information, Manufacturing Base and Competitors
Table 34. OZ Biosciences Major Business
Table 35. OZ Biosciences Biological Vaccines Adjuvants Product and Services
Table 36. OZ Biosciences Biological Vaccines Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 37. OZ Biosciences Recent Developments/Updates
Table 38. Phibro Animal Health Corporation Basic Information, Manufacturing Base and Competitors
Table 39. Phibro Animal Health Corporation Major Business
Table 40. Phibro Animal Health Corporation Biological Vaccines Adjuvants Product and Services
Table 41. Phibro Animal Health Corporation Biological Vaccines Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 42. Phibro Animal Health Corporation Recent Developments/Updates
Table 43. Associated British Foods Basic Information, Manufacturing Base and Competitors
Table 44. Associated British Foods Major Business
Table 45. Associated British Foods Biological Vaccines Adjuvants Product and Services
Table 46. Associated British Foods Biological Vaccines Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 47. Associated British Foods Recent Developments/Updates
Table 48. InvivoGen Basic Information, Manufacturing Base and Competitors
Table 49. InvivoGen Major Business
Table 50. InvivoGen Biological Vaccines Adjuvants Product and Services
Table 51. InvivoGen Biological Vaccines Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 52. InvivoGen Recent Developments/Updates
Table 53. Merck KGaA Basic Information, Manufacturing Base and Competitors
Table 54. Merck KGaA Major Business
Table 55. Merck KGaA Biological Vaccines Adjuvants Product and Services
Table 56. Merck KGaA Biological Vaccines Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 57. Merck KGaA Recent Developments/Updates
Table 58. CSL Limited Basic Information, Manufacturing Base and Competitors
Table 59. CSL Limited Major Business
Table 60. CSL Limited Biological Vaccines Adjuvants Product and Services
Table 61. CSL Limited Biological Vaccines Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 62. CSL Limited Recent Developments/Updates
Table 63. Vertellus Basic Information, Manufacturing Base and Competitors
Table 64. Vertellus Major Business
Table 65. Vertellus Biological Vaccines Adjuvants Product and Services
Table 66. Vertellus Biological Vaccines Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 67. Vertellus Recent Developments/Updates
Table 68. Allergy Therapeutics Basic Information, Manufacturing Base and Competitors
Table 69. Allergy Therapeutics Major Business
Table 70. Allergy Therapeutics Biological Vaccines Adjuvants Product and Services
Table 71. Allergy Therapeutics Biological Vaccines Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 72. Allergy Therapeutics Recent Developments/Updates
Table 73. Riboxx GmbH Basic Information, Manufacturing Base and Competitors
Table 74. Riboxx GmbH Major Business
Table 75. Riboxx GmbH Biological Vaccines Adjuvants Product and Services
Table 76. Riboxx GmbH Biological Vaccines Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Riboxx GmbH Recent Developments/Updates
Table 78. CaPtivat? Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 79. CaPtivat? Pharmaceuticals Major Business
Table 80. CaPtivat? Pharmaceuticals Biological Vaccines Adjuvants Product and Services
Table 81. CaPtivat? Pharmaceuticals Biological Vaccines Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 82. CaPtivat? Pharmaceuticals Recent Developments/Updates
Table 83. EuBiologics Basic Information, Manufacturing Base and Competitors
Table 84. EuBiologics Major Business
Table 85. EuBiologics Biological Vaccines Adjuvants Product and Services
Table 86. EuBiologics Biological Vaccines Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 87. EuBiologics Recent Developments/Updates
Table 88. Pacific GeneTech Basic Information, Manufacturing Base and Competitors
Table 89. Pacific GeneTech Major Business
Table 90. Pacific GeneTech Biological Vaccines Adjuvants Product and Services
Table 91. Pacific GeneTech Biological Vaccines Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 92. Pacific GeneTech Recent Developments/Updates
Table 93. Hawaii Biotech Basic Information, Manufacturing Base and Competitors
Table 94. Hawaii Biotech Major Business
Table 95. Hawaii Biotech Biological Vaccines Adjuvants Product and Services
Table 96. Hawaii Biotech Biological Vaccines Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 97. Hawaii Biotech Recent Developments/Updates
Table 98. Vaxine Pty Ltd. Basic Information, Manufacturing Base and Competitors
Table 99. Vaxine Pty Ltd. Major Business
Table 100. Vaxine Pty Ltd. Biological Vaccines Adjuvants Product and Services
Table 101. Vaxine Pty Ltd. Biological Vaccines Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 102. Vaxine Pty Ltd. Recent Developments/Updates
Table 103. Creative Diagnostics Basic Information, Manufacturing Base and Competitors
Table 104. Creative Diagnostics Major Business
Table 105. Creative Diagnostics Biological Vaccines Adjuvants Product and Services
Table 106. Creative Diagnostics Biological Vaccines Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. Creative Diagnostics Recent Developments/Updates
Table 108. LiteVax BV Basic Information, Manufacturing Base and Competitors
Table 109. LiteVax BV Major Business
Table 110. LiteVax BV Biological Vaccines Adjuvants Product and Services
Table 111. LiteVax BV Biological Vaccines Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 112. LiteVax BV Recent Developments/Updates
Table 113. Mukta Industries Basic Information, Manufacturing Base and Competitors
Table 114. Mukta Industries Major Business
Table 115. Mukta Industries Biological Vaccines Adjuvants Product and Services
Table 116. Mukta Industries Biological Vaccines Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 117. Mukta Industries Recent Developments/Updates
Table 118. Oncovir Basic Information, Manufacturing Base and Competitors
Table 119. Oncovir Major Business
Table 120. Oncovir Biological Vaccines Adjuvants Product and Services
Table 121. Oncovir Biological Vaccines Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 122. Oncovir Recent Developments/Updates
Table 123. TiterMax USA Basic Information, Manufacturing Base and Competitors
Table 124. TiterMax USA Major Business
Table 125. TiterMax USA Biological Vaccines Adjuvants Product and Services
Table 126. TiterMax USA Biological Vaccines Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 127. TiterMax USA Recent Developments/Updates
Table 128. Global Biological Vaccines Adjuvants Sales Quantity by Manufacturer (2017-2022) & (K Units)
Table 129. Global Biological Vaccines Adjuvants Revenue by Manufacturer (2017-2022) & (USD Million)
Table 130. Global Biological Vaccines Adjuvants Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 131. Market Position of Manufacturers in Biological Vaccines Adjuvants, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2021
Table 132. Head Office and Biological Vaccines Adjuvants Production Site of Key Manufacturer
Table 133. Biological Vaccines Adjuvants Market: Company Product Type Footprint
Table 134. Biological Vaccines Adjuvants Market: Company Product Application Footprint
Table 135. Biological Vaccines Adjuvants New Market Entrants and Barriers to Market Entry
Table 136. Biological Vaccines Adjuvants Mergers, Acquisition, Agreements, and Collaborations
Table 137. Global Biological Vaccines Adjuvants Sales Quantity by Region (2017-2022) & (K Units)
Table 138. Global Biological Vaccines Adjuvants Sales Quantity by Region (2023-2028) & (K Units)
Table 139. Global Biological Vaccines Adjuvants Consumption Value by Region (2017-2022) & (USD Million)
Table 140. Global Biological Vaccines Adjuvants Consumption Value by Region (2023-2028) & (USD Million)
Table 141. Global Biological Vaccines Adjuvants Average Price by Region (2017-2022) & (US$/Unit)
Table 142. Global Biological Vaccines Adjuvants Average Price by Region (2023-2028) & (US$/Unit)
Table 143. Global Biological Vaccines Adjuvants Sales Quantity by Type (2017-2022) & (K Units)
Table 144. Global Biological Vaccines Adjuvants Sales Quantity by Type (2023-2028) & (K Units)
Table 145. Global Biological Vaccines Adjuvants Consumption Value by Type (2017-2022) & (USD Million)
Table 146. Global Biological Vaccines Adjuvants Consumption Value by Type (2023-2028) & (USD Million)
Table 147. Global Biological Vaccines Adjuvants Average Price by Type (2017-2022) & (US$/Unit)
Table 148. Global Biological Vaccines Adjuvants Average Price by Type (2023-2028) & (US$/Unit)
Table 149. Global Biological Vaccines Adjuvants Sales Quantity by Application (2017-2022) & (K Units)
Table 150. Global Biological Vaccines Adjuvants Sales Quantity by Application (2023-2028) & (K Units)
Table 151. Global Biological Vaccines Adjuvants Consumption Value by Application (2017-2022) & (USD Million)
Table 152. Global Biological Vaccines Adjuvants Consumption Value by Application (2023-2028) & (USD Million)
Table 153. Global Biological Vaccines Adjuvants Average Price by Application (2017-2022) & (US$/Unit)
Table 154. Global Biological Vaccines Adjuvants Average Price by Application (2023-2028) & (US$/Unit)
Table 155. North America Biological Vaccines Adjuvants Sales Quantity by Type (2017-2022) & (K Units)
Table 156. North America Biological Vaccines Adjuvants Sales Quantity by Type (2023-2028) & (K Units)
Table 157. North America Biological Vaccines Adjuvants Sales Quantity by Application (2017-2022) & (K Units)
Table 158. North America Biological Vaccines Adjuvants Sales Quantity by Application (2023-2028) & (K Units)
Table 159. North America Biological Vaccines Adjuvants Sales Quantity by Country (2017-2022) & (K Units)
Table 160. North America Biological Vaccines Adjuvants Sales Quantity by Country (2023-2028) & (K Units)
Table 161. North America Biological Vaccines Adjuvants Consumption Value by Country (2017-2022) & (USD Million)
Table 162. North America Biological Vaccines Adjuvants Consumption Value by Country (2023-2028) & (USD Million)
Table 163. Europe Biological Vaccines Adjuvants Sales Quantity by Type (2017-2022) & (K Units)
Table 164. Europe Biological Vaccines Adjuvants Sales Quantity by Type (2023-2028) & (K Units)
Table 165. Europe Biological Vaccines Adjuvants Sales Quantity by Application (2017-2022) & (K Units)
Table 166. Europe Biological Vaccines Adjuvants Sales Quantity by Application (2023-2028) & (K Units)
Table 167. Europe Biological Vaccines Adjuvants Sales Quantity by Country (2017-2022) & (K Units)
Table 168. Europe Biological Vaccines Adjuvants Sales Quantity by Country (2023-2028) & (K Units)
Table 169. Europe Biological Vaccines Adjuvants Consumption Value by Country (2017-2022) & (USD Million)
Table 170. Europe Biological Vaccines Adjuvants Consumption Value by Country (2023-2028) & (USD Million)
Table 171. Asia-Pacific Biological Vaccines Adjuvants Sales Quantity by Type (2017-2022) & (K Units)
Table 172. Asia-Pacific Biological Vaccines Adjuvants Sales Quantity by Type (2023-2028) & (K Units)
Table 173. Asia-Pacific Biological Vaccines Adjuvants Sales Quantity by Application (2017-2022) & (K Units)
Table 174. Asia-Pacific Biological Vaccines Adjuvants Sales Quantity by Application (2023-2028) & (K Units)
Table 175. Asia-Pacific Biological Vaccines Adjuvants Sales Quantity by Region (2017-2022) & (K Units)
Table 176. Asia-Pacific Biological Vaccines Adjuvants Sales Quantity by Region (2023-2028) & (K Units)
Table 177. Asia-Pacific Biological Vaccines Adjuvants Consumption Value by Region (2017-2022) & (USD Million)
Table 178. Asia-Pacific Biological Vaccines Adjuvants Consumption Value by Region (2023-2028) & (USD Million)
Table 179. South America Biological Vaccines Adjuvants Sales Quantity by Type (2017-2022) & (K Units)
Table 180. South America Biological Vaccines Adjuvants Sales Quantity by Type (2023-2028) & (K Units)
Table 181. South America Biological Vaccines Adjuvants Sales Quantity by Application (2017-2022) & (K Units)
Table 182. South America Biological Vaccines Adjuvants Sales Quantity by Application (2023-2028) & (K Units)
Table 183. South America Biological Vaccines Adjuvants Sales Quantity by Country (2017-2022) & (K Units)
Table 184. South America Biological Vaccines Adjuvants Sales Quantity by Country (2023-2028) & (K Units)
Table 185. South America Biological Vaccines Adjuvants Consumption Value by Country (2017-2022) & (USD Million)
Table 186. South America Biological Vaccines Adjuvants Consumption Value by Country (2023-2028) & (USD Million)
Table 187. Middle East & Africa Biological Vaccines Adjuvants Sales Quantity by Type (2017-2022) & (K Units)
Table 188. Middle East & Africa Biological Vaccines Adjuvants Sales Quantity by Type (2023-2028) & (K Units)
Table 189. Middle East & Africa Biological Vaccines Adjuvants Sales Quantity by Application (2017-2022) & (K Units)
Table 190. Middle East & Africa Biological Vaccines Adjuvants Sales Quantity by Application (2023-2028) & (K Units)
Table 191. Middle East & Africa Biological Vaccines Adjuvants Sales Quantity by Region (2017-2022) & (K Units)
Table 192. Middle East & Africa Biological Vaccines Adjuvants Sales Quantity by Region (2023-2028) & (K Units)
Table 193. Middle East & Africa Biological Vaccines Adjuvants Consumption Value by Region (2017-2022) & (USD Million)
Table 194. Middle East & Africa Biological Vaccines Adjuvants Consumption Value by Region (2023-2028) & (USD Million)
Table 195. Biological Vaccines Adjuvants Raw Material
Table 196. Key Manufacturers of Biological Vaccines Adjuvants Raw Materials
Table 197. Biological Vaccines Adjuvants Typical Distributors
Table 198. Biological Vaccines Adjuvants Typical Customers
LIST OF FIGURES
Figure 1. Biological Vaccines Adjuvants Picture
Figure 2. Global Biological Vaccines Adjuvants Consumption Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 3. Global Biological Vaccines Adjuvants Consumption Value Market Share by Type in 2021
Figure 4. Aluminum Adjuvant Examples
Figure 5. Emulsions Adjuvant Examples
Figure 6. Others Examples
Figure 7. Global Biological Vaccines Adjuvants Consumption Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 8. Global Biological Vaccines Adjuvants Consumption Value Market Share by Application in 2021
Figure 9. Human Vaccine Examples
Figure 10. Veterinary Vaccine Examples
Figure 11. Global Biological Vaccines Adjuvants Consumption Value, (USD Million): 2017 & 2021 & 2028
Figure 12. Global Biological Vaccines Adjuvants Consumption Value and Forecast (2017-2028) & (USD Million)
Figure 13. Global Biological Vaccines Adjuvants Sales Quantity (2017-2028) & (K Units)
Figure 14. Global Biological Vaccines Adjuvants Average Price (2017-2028) & (US$/Unit)
Figure 15. Global Biological Vaccines Adjuvants Sales Quantity Market Share by Manufacturer in 2021
Figure 16. Global Biological Vaccines Adjuvants Consumption Value Market Share by Manufacturer in 2021
Figure 17. Producer Shipments of Biological Vaccines Adjuvants by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Biological Vaccines Adjuvants Manufacturer (Consumption Value) Market Share in 2021
Figure 19. Top 6 Biological Vaccines Adjuvants Manufacturer (Consumption Value) Market Share in 2021
Figure 20. Global Biological Vaccines Adjuvants Sales Quantity Market Share by Region (2017-2028)
Figure 21. Global Biological Vaccines Adjuvants Consumption Value Market Share by Region (2017-2028)
Figure 22. North America Biological Vaccines Adjuvants Consumption Value (2017-2028) & (USD Million)
Figure 23. Europe Biological Vaccines Adjuvants Consumption Value (2017-2028) & (USD Million)
Figure 24. Asia-Pacific Biological Vaccines Adjuvants Consumption Value (2017-2028) & (USD Million)
Figure 25. South America Biological Vaccines Adjuvants Consumption Value (2017-2028) & (USD Million)
Figure 26. Middle East & Africa Biological Vaccines Adjuvants Consumption Value (2017-2028) & (USD Million)
Figure 27. Global Biological Vaccines Adjuvants Sales Quantity Market Share by Type (2017-2028)
Figure 28. Global Biological Vaccines Adjuvants Consumption Value Market Share by Type (2017-2028)
Figure 29. Global Biological Vaccines Adjuvants Average Price by Type (2017-2028) & (US$/Unit)
Figure 30. Global Biological Vaccines Adjuvants Sales Quantity Market Share by Application (2017-2028)
Figure 31. Global Biological Vaccines Adjuvants Consumption Value Market Share by Application (2017-2028)
Figure 32. Global Biological Vaccines Adjuvants Average Price by Application (2017-2028) & (US$/Unit)
Figure 33. North America Biological Vaccines Adjuvants Sales Quantity Market Share by Type (2017-2028)
Figure 34. North America Biological Vaccines Adjuvants Sales Quantity Market Share by Application (2017-2028)
Figure 35. North America Biological Vaccines Adjuvants Sales Quantity Market Share by Country (2017-2028)
Figure 36. North America Biological Vaccines Adjuvants Consumption Value Market Share by Country (2017-2028)
Figure 37. United States Biological Vaccines Adjuvants Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 38. Canada Biological Vaccines Adjuvants Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 39. Mexico Biological Vaccines Adjuvants Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 40. Europe Biological Vaccines Adjuvants Sales Quantity Market Share by Type (2017-2028)
Figure 41. Europe Biological Vaccines Adjuvants Sales Quantity Market Share by Application (2017-2028)
Figure 42. Europe Biological Vaccines Adjuvants Sales Quantity Market Share by Country (2017-2028)
Figure 43. Europe Biological Vaccines Adjuvants Consumption Value Market Share by Country (2017-2028)
Figure 44. Germany Biological Vaccines Adjuvants Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 45. France Biological Vaccines Adjuvants Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 46. United Kingdom Biological Vaccines Adjuvants Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 47. Russia Biological Vaccines Adjuvants Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 48. Italy Biological Vaccines Adjuvants Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 49. Asia-Pacific Biological Vaccines Adjuvants Sales Quantity Market Share by Region (2017-2028)
Figure 50. Asia-Pacific Biological Vaccines Adjuvants Sales Quantity Market Share by Application (2017-2028)
Figure 51. Asia-Pacific Biological Vaccines Adjuvants Sales Quantity Market Share by Region (2017-2028)
Figure 52. Asia-Pacific Biological Vaccines Adjuvants Consumption Value Market Share by Region (2017-2028)
Figure 53. China Biological Vaccines Adjuvants Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 54. Japan Biological Vaccines Adjuvants Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 55. Korea Biological Vaccines Adjuvants Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 56. India Biological Vaccines Adjuvants Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 57. Southeast Asia Biological Vaccines Adjuvants Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 58. Australia Biological Vaccines Adjuvants Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 59. South America Biological Vaccines Adjuvants Sales Quantity Market Share by Type (2017-2028)
Figure 60. South America Biological Vaccines Adjuvants Sales Quantity Market Share by Application (2017-2028)
Figure 61. South America Biological Vaccines Adjuvants Sales Quantity Market Share by Country (2017-2028)
Figure 62. South America Biological Vaccines Adjuvants Consumption Value Market Share by Country (2017-2028)
Figure 63. Brazil Biological Vaccines Adjuvants Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 64. Argentina Biological Vaccines Adjuvants Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 65. Middle East & Africa Biological Vaccines Adjuvants Sales Quantity Market Share by Type (2017-2028)
Figure 66. Middle East & Africa Biological Vaccines Adjuvants Sales Quantity Market Share by Application (2017-2028)
Figure 67. Middle East & Africa Biological Vaccines Adjuvants Sales Quantity Market Share by Region (2017-2028)
Figure 68. Middle East & Africa Biological Vaccines Adjuvants Consumption Value Market Share by Region (2017-2028)
Figure 69. Turkey Biological Vaccines Adjuvants Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 70. Egypt Biological Vaccines Adjuvants Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 71. Saudi Arabia Biological Vaccines Adjuvants Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 72. South Africa Biological Vaccines Adjuvants Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 73. Biological Vaccines Adjuvants Market Drivers
Figure 74. Biological Vaccines Adjuvants Market Restraints
Figure 75. Biological Vaccines Adjuvants Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Biological Vaccines Adjuvants in 2021
Figure 78. Manufacturing Process Analysis of Biological Vaccines Adjuvants
Figure 79. Biological Vaccines Adjuvants Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
Figure 1. Biological Vaccines Adjuvants Picture
Figure 2. Global Biological Vaccines Adjuvants Consumption Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 3. Global Biological Vaccines Adjuvants Consumption Value Market Share by Type in 2021
Figure 4. Aluminum Adjuvant Examples
Figure 5. Emulsions Adjuvant Examples
Figure 6. Others Examples
Figure 7. Global Biological Vaccines Adjuvants Consumption Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 8. Global Biological Vaccines Adjuvants Consumption Value Market Share by Application in 2021
Figure 9. Human Vaccine Examples
Figure 10. Veterinary Vaccine Examples
Figure 11. Global Biological Vaccines Adjuvants Consumption Value, (USD Million): 2017 & 2021 & 2028
Figure 12. Global Biological Vaccines Adjuvants Consumption Value and Forecast (2017-2028) & (USD Million)
Figure 13. Global Biological Vaccines Adjuvants Sales Quantity (2017-2028) & (K Units)
Figure 14. Global Biological Vaccines Adjuvants Average Price (2017-2028) & (US$/Unit)
Figure 15. Global Biological Vaccines Adjuvants Sales Quantity Market Share by Manufacturer in 2021
Figure 16. Global Biological Vaccines Adjuvants Consumption Value Market Share by Manufacturer in 2021
Figure 17. Producer Shipments of Biological Vaccines Adjuvants by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Biological Vaccines Adjuvants Manufacturer (Consumption Value) Market Share in 2021
Figure 19. Top 6 Biological Vaccines Adjuvants Manufacturer (Consumption Value) Market Share in 2021
Figure 20. Global Biological Vaccines Adjuvants Sales Quantity Market Share by Region (2017-2028)
Figure 21. Global Biological Vaccines Adjuvants Consumption Value Market Share by Region (2017-2028)
Figure 22. North America Biological Vaccines Adjuvants Consumption Value (2017-2028) & (USD Million)
Figure 23. Europe Biological Vaccines Adjuvants Consumption Value (2017-2028) & (USD Million)
Figure 24. Asia-Pacific Biological Vaccines Adjuvants Consumption Value (2017-2028) & (USD Million)
Figure 25. South America Biological Vaccines Adjuvants Consumption Value (2017-2028) & (USD Million)
Figure 26. Middle East & Africa Biological Vaccines Adjuvants Consumption Value (2017-2028) & (USD Million)
Figure 27. Global Biological Vaccines Adjuvants Sales Quantity Market Share by Type (2017-2028)
Figure 28. Global Biological Vaccines Adjuvants Consumption Value Market Share by Type (2017-2028)
Figure 29. Global Biological Vaccines Adjuvants Average Price by Type (2017-2028) & (US$/Unit)
Figure 30. Global Biological Vaccines Adjuvants Sales Quantity Market Share by Application (2017-2028)
Figure 31. Global Biological Vaccines Adjuvants Consumption Value Market Share by Application (2017-2028)
Figure 32. Global Biological Vaccines Adjuvants Average Price by Application (2017-2028) & (US$/Unit)
Figure 33. North America Biological Vaccines Adjuvants Sales Quantity Market Share by Type (2017-2028)
Figure 34. North America Biological Vaccines Adjuvants Sales Quantity Market Share by Application (2017-2028)
Figure 35. North America Biological Vaccines Adjuvants Sales Quantity Market Share by Country (2017-2028)
Figure 36. North America Biological Vaccines Adjuvants Consumption Value Market Share by Country (2017-2028)
Figure 37. United States Biological Vaccines Adjuvants Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 38. Canada Biological Vaccines Adjuvants Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 39. Mexico Biological Vaccines Adjuvants Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 40. Europe Biological Vaccines Adjuvants Sales Quantity Market Share by Type (2017-2028)
Figure 41. Europe Biological Vaccines Adjuvants Sales Quantity Market Share by Application (2017-2028)
Figure 42. Europe Biological Vaccines Adjuvants Sales Quantity Market Share by Country (2017-2028)
Figure 43. Europe Biological Vaccines Adjuvants Consumption Value Market Share by Country (2017-2028)
Figure 44. Germany Biological Vaccines Adjuvants Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 45. France Biological Vaccines Adjuvants Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 46. United Kingdom Biological Vaccines Adjuvants Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 47. Russia Biological Vaccines Adjuvants Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 48. Italy Biological Vaccines Adjuvants Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 49. Asia-Pacific Biological Vaccines Adjuvants Sales Quantity Market Share by Region (2017-2028)
Figure 50. Asia-Pacific Biological Vaccines Adjuvants Sales Quantity Market Share by Application (2017-2028)
Figure 51. Asia-Pacific Biological Vaccines Adjuvants Sales Quantity Market Share by Region (2017-2028)
Figure 52. Asia-Pacific Biological Vaccines Adjuvants Consumption Value Market Share by Region (2017-2028)
Figure 53. China Biological Vaccines Adjuvants Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 54. Japan Biological Vaccines Adjuvants Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 55. Korea Biological Vaccines Adjuvants Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 56. India Biological Vaccines Adjuvants Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 57. Southeast Asia Biological Vaccines Adjuvants Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 58. Australia Biological Vaccines Adjuvants Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 59. South America Biological Vaccines Adjuvants Sales Quantity Market Share by Type (2017-2028)
Figure 60. South America Biological Vaccines Adjuvants Sales Quantity Market Share by Application (2017-2028)
Figure 61. South America Biological Vaccines Adjuvants Sales Quantity Market Share by Country (2017-2028)
Figure 62. South America Biological Vaccines Adjuvants Consumption Value Market Share by Country (2017-2028)
Figure 63. Brazil Biological Vaccines Adjuvants Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 64. Argentina Biological Vaccines Adjuvants Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 65. Middle East & Africa Biological Vaccines Adjuvants Sales Quantity Market Share by Type (2017-2028)
Figure 66. Middle East & Africa Biological Vaccines Adjuvants Sales Quantity Market Share by Application (2017-2028)
Figure 67. Middle East & Africa Biological Vaccines Adjuvants Sales Quantity Market Share by Region (2017-2028)
Figure 68. Middle East & Africa Biological Vaccines Adjuvants Consumption Value Market Share by Region (2017-2028)
Figure 69. Turkey Biological Vaccines Adjuvants Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 70. Egypt Biological Vaccines Adjuvants Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 71. Saudi Arabia Biological Vaccines Adjuvants Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 72. South Africa Biological Vaccines Adjuvants Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 73. Biological Vaccines Adjuvants Market Drivers
Figure 74. Biological Vaccines Adjuvants Market Restraints
Figure 75. Biological Vaccines Adjuvants Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Biological Vaccines Adjuvants in 2021
Figure 78. Manufacturing Process Analysis of Biological Vaccines Adjuvants
Figure 79. Biological Vaccines Adjuvants Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
